Largest pharmaceutical companies in the United States by earnings
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Johnson & Johnson leads the 44 pharmaceutical companies in the United States ranked by earnings, at SGD 34.5B, ahead of Eli Lilly (SGD 26.6B) and Merck & Co (SGD 23.5B). Figures as of 20 Nov 2026, 12:48 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 44
- First
- Johnson & JohnsonSGD 34.5B
- Median
- -SGD 61.5M
- Combined market value
- SGD 4.81T
- Countries
- 1
Market values as of .
United States▾
All sectors▾
Pharmaceuticals▾
| # | Company | Earnings ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Johnson & JohnsonJNJ · Health Care | SGD 34.5B | SGD 828.5B | SGD 344.18 | 2.04% down | 31% up | ||
| 2 | Eli LillyLLY · Health Care | SGD 26.6B | SGD 1.55T | SGD 1,740.74 | 2.29% down | 28% up | ||
| 3 | Merck & CoMRK · Health Care | SGD 23.5B | SGD 421.8B | SGD 171.11 | 3.61% down | 36% up | ||
| 4 | PfizerPFE · Health Care | SGD 10B | SGD 202.2B | SGD 35.48 | 1.85% down | 10% up | ||
| 5 | Bristol-Myers SquibbBMY · Health Care | SGD 9.1B | SGD 153.6B | SGD 75.16 | 2.05% down | 26% up | ||
| 6 | Abbott LaboratoriesABT · Health Care | SGD 8.4B | SGD 231.8B | SGD 133.82 | 0.58% down | 19% down | ||
| 7 | Regeneron PharmaceuticalsREGN · Health Care | SGD 5.8B | SGD 123.1B | SGD 1,189.60 | 2.35% down | 22% up | ||
| 8 | AbbVieABBV · Health Care | SGD 5.4B | SGD 645.7B | SGD 365.30 | 0.86% down | 20% up | ||
| 9 | Vertex PharmaceuticalsVRTX · Health Care | SGD 5.1B | SGD 170.1B | SGD 670.80 | 2.94% down | 22% up | ||
| 10 | ZoetisZTS · Health Care | SGD 3.4B | SGD 42.3B | SGD 104.09 | 5.59% down | 34% down | ||
| 11 | United TherapeuticsUTHR · Health Care | SGD 1.7B | SGD 30.7B | SGD 720.33 | 3.16% down | 18% up | ||
| 12 | Royalty PharmaRPRX · Health Care | SGD 993.3M | SGD 50.2B | SGD 87.25 | 1.38% down | 74% up | ||
| 13 | PTC TherapeuticsPTCT · Health Care | SGD 879.5M | SGD 6.3B | SGD 75.14 | 3.16% down | 26% down | ||
| 14 | TG TherapeuticsTGTX · Health Care | SGD 576.1M | SGD 12.6B | SGD 83.59 | 1.88% down | 103% up | ||
| 15 | BioMarin PharmaceuticalBMRN · Health Care | SGD 449.5M | SGD 15.3B | SGD 79.13 | 0.02% down | 12% up | ||
| 16 | Alnylam PharmaceuticalsALNY · Health Care | SGD 404.2M | SGD 25.5B | SGD 190.45 | 1.06% down | 66% down | ||
| 17 | Ligand PharmaceuticalsLGND · Health Care | SGD 160.3M | SGD 7.4B | SGD 369.68 | 3.94% down | 44% up | ||
| 18 | Corcept TherapeuticsCORT · Health Care | SGD 128.4M | SGD 9.2B | SGD 83.72 | 4.15% down | 16% down | ||
| 19 | Amneal PharmaceuticalsAMRX · Health Care | SGD 92.8M | SGD 9.6B | SGD 27.56 | 2.24% down | 79% up | ||
| 20 | Arrowhead PharmaceuticalsARWR · Health Care | -SGD 2.1M | SGD 8B | SGD 56.24 | 1.25% up | 8% up | ||
| 21 | Mirum PharmaceuticalsMIRM · Health Care | -SGD 30.1M | SGD 8B | SGD 123.05 | 3.27% up | 35% up | ||
| 22 | Travere TherapeuticsTVTX · Health Care | -SGD 32.9M | SGD 6B | SGD 62.23 | 3.86% down | 39% up | ||
| 23 | VeradermicsMANE · Health Care | -SGD 90.2M | SGD 6.8B | SGD 160.26 | 0.38% down | 230% up | ||
| 24 | Belite BioBLTE · Health Care | -SGD 100M | SGD 7.9B | SGD 194.57 | 3.33% down | 25% up | ||
| 25 | Oruka TherapeuticsORKA · Health Care | -SGD 135.8M | SGD 8.5B | SGD 125.71 | 1.91% up | 233% up | ||
| 26 | ErascaERAS · Health Care | -SGD 160.5M | SGD 6.4B | SGD 18.32 | 3.34% up | 387% up | ||
| 27 | Protagonist TherapeuticsPTGX · Health Care | -SGD 167.7M | SGD 10.4B | SGD 159.78 | 2.47% down | 45% up | ||
| 28 | Spyre TherapeuticsSYRE · Health Care | -SGD 200M | SGD 11.9B | SGD 125.78 | 3.77% down | 302% up | ||
| 29 | Dianthus TherapeuticsDNTH · Health Care | -SGD 209.2M | SGD 6.2B | SGD 109.29 | 1.01% up | 105% up | ||
| 30 | Edgewise TherapeuticsEWTX · Health Care | -SGD 216.2M | SGD 5.8B | SGD 53.04 | 0.48% down | 82% up | ||
| 31 | Axsome TherapeuticsAXSM · Health Care | -SGD 236M | SGD 9.2B | SGD 174.81 | 1.25% up | 9% down | ||
| 32 | Definium TherapeuticsDFTX · Health Care | -SGD 236.8M | SGD 5.2B | SGD 37.98 | 1.24% up | 176% up | ||
| 33 | Rhythm PharmaceuticalsRYTM · Health Care | -SGD 253.2M | SGD 10.4B | SGD 150.48 | 1.88% down | 15% up | ||
| 34 | Elanco Animal HealthELAN · Health Care | -SGD 298.9M | SGD 16.9B | SGD 33.87 | 1.54% down | 18% up | ||
| 35 | Madrigal PharmaceuticalsMDGL · Health Care | -SGD 371.4M | SGD 11.9B | SGD 511.15 | 0.34% down | 28% down | ||
| 36 | Legend BiotechLEGN · Health Care | -SGD 382.4M | SGD 4B | SGD 20.74 | 0.92% down | 43% down | ||
| 37 | Praxis Precision MedicinesPRAX · Health Care | -SGD 390.7M | SGD 11.2B | SGD 400.55 | 1.87% up | 83% up | ||
| 38 | Cogent BiosciencesCOGT · Health Care | -SGD 423.8M | SGD 6.2B | SGD 35.74 | 0.25% down | 25% down | ||
| 39 | Ionis PharmaceuticalsIONS · Health Care | -SGD 491.4M | SGD 5.8B | SGD 35.07 | 0.62% down | 64% down | ||
| 40 | BridgeBio PharmaBBIO · Health Care | -SGD 944.3M | SGD 19.6B | SGD 100.72 | 0.22% up | 15% up | ||
| 41 | CytokineticsCYTK · Health Care | -SGD 1B | SGD 9.2B | SGD 66.30 | 0.27% up | 21% down | ||
| 42 | Summit TherapeuticsSMMT · Health Care | -SGD 1.4B | SGD 10.9B | SGD 13.62 | 0.67% up | 35% down | ||
| 43 | InsmedINSM · Health Care | -SGD 1.6B | SGD 40.8B | SGD 186.12 | 20.58% up | 27% down | ||
| 44 | ViatrisVTRS · Health Care | -SGD 4.5B | SGD 29.4B | SGD 25.61 | 1.97% down | 90% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Earnings is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 1.2884 SGD).
Questions and answers
Which pharmaceutical companies in the United States rank first by earnings?
Johnson & Johnson (SGD 34.5B), Eli Lilly (SGD 26.6B) and Merck & Co (SGD 23.5B) are the top three of the 44 pharmaceutical companies in the United States ranked by earnings as of 20 Nov 2026, 12:48 UTC.
How many pharmaceutical companies in the United States are in this ranking?
44 are ranked by earnings.
What are these pharmaceutical companies in the United States worth together?
The 44 pharmaceutical companies in the United States ranked by earnings have a combined market value of SGD 4.81T as of 20 Nov 2026, 12:48 UTC.
What does ranking by earnings measure?
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Learn how this ranking works
All markets guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
Cite this page
Funkfolio, “Largest pharmaceutical companies in the United States by earnings”, data as of 20 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?country=united-states&by=earnings
Underlying data: Yahoo Finance; SEC EDGAR.